Hyphens Pharma（1J5）年報查詢
HYPHENS PHARMA INTL LIMITED・新加坡交易所凱利板上市，SSIC 原生分類為Wholesale and Retail Trade（新加坡標準行業分類，無官方中文版）。 本頁收錄該公司歷年年報與相關報告，PDF 由新加坡交易所（SGX）直接提供。
Hyphens Pharma 是做什麼的
Hyphens Pharma International Limited and its subsidiaries (the "Group") is one of Singapores leading specialty pharmaceutical and consumer healthcare groups leveraging on its diverse footprint in ASEAN countries. The Group has a direct presence in five ASEAN countries, namely, Singapore, Vietnam, Malaysia, Indonesia and the Philippines, supplemented by a marketing and distribution network covering five additional jurisdictions, namely, Hong Kong, Myanmar, Brunei, Cambodia and Oman. Singapore is the Groups regional headquarters, where its strategic planning, finance, regulatory affairs, research and development, legal, business development and logistics operations are based.
The Groups core business comprises the following segments: specialty pharma principals, proprietary brands, and medical hypermart and digital. Besides marketing and selling a range of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States, the Group also develops, markets and sells its own proprietary range of dermatological products and health supplement products. In addition, the Group operates a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies, to supply pharmaceutical products and medical supplies.
Hyphens Pharma 歷年年報與報告
關於 Hyphens Pharma 年報
Hyphens Pharma（1J5）年報去哪裡下載？
本頁每個年度都附有 PDF 連結，檔案直接來自新加坡交易所（SGX）的公司公告系統。 目前收錄 8 份年報，年度涵蓋 2018 至 2025。
新加坡上市公司要不要出季報？
2020 年起 SGX 取消了強制季報，改為以風險為基礎——只有特定情況的公司才須刊發季度財務報告。 所以多數新加坡公司一年只有半年度報告與年報兩份定期報告， 本站收錄的季報數量因此偏少，那是制度使然不是資料缺漏。
什麼是永續報告書？
SGX 自 2016 年起要求上市公司刊發永續報告（Sustainability Report），揭露環境、社會與治理（ESG）事項。 它與年報是分開的兩份文件，本站兩種都收。
主板和凱利板有什麼不同？
凱利板（Catalist）門檻較低、面向成長期的中小型企業，由保薦人（sponsor）制度監督； 主板（Mainboard）則有較高的獲利與市值要求。兩者的年報揭露義務相近。